224 related articles for article (PubMed ID: 34060477)
1. Lung-resident memory B cells protect against bacterial pneumonia.
Barker KA; Etesami NS; Shenoy AT; Arafa EI; Lyon de Ana C; Smith NM; Martin IM; Goltry WN; Barron AM; Browning JL; Kathuria H; Belkina AC; Guillon A; Zhong X; Crossland NA; Jones MR; Quinton LJ; Mizgerd JP
J Clin Invest; 2021 Jun; 131(11):. PubMed ID: 34060477
[TBL] [Abstract][Full Text] [Related]
2. Regionally compartmentalized resident memory T cells mediate naturally acquired protection against pneumococcal pneumonia.
Smith NM; Wasserman GA; Coleman FT; Hilliard KL; Yamamoto K; Lipsitz E; Malley R; Dooms H; Jones MR; Quinton LJ; Mizgerd JP
Mucosal Immunol; 2018 Jan; 11(1):220-235. PubMed ID: 28513594
[TBL] [Abstract][Full Text] [Related]
3. B cells in the pneumococcus-infected lung are heterogeneous and require CD4
Etesami NS; Barker KA; Shenoy AT; De Ana CL; Arafa EI; Grifno GN; Matschulat AM; Vannini ME; Pihl RMF; Breen MP; Soucy AM; Goltry WN; Ha CT; Betsuyaku H; Browning JL; Varelas X; Traber KE; Jones MR; Quinton LJ; Maglione PJ; Nia HT; Belkina AC; Mizgerd JP
Front Immunol; 2024; 15():1382638. PubMed ID: 38715601
[TBL] [Abstract][Full Text] [Related]
4. The establishment of resident memory B cells in the lung requires local antigen encounter.
Allie SR; Bradley JE; Mudunuru U; Schultz MD; Graf BA; Lund FE; Randall TD
Nat Immunol; 2019 Jan; 20(1):97-108. PubMed ID: 30510223
[TBL] [Abstract][Full Text] [Related]
5. Lung CD4
Shenoy AT; Wasserman GA; Arafa EI; Wooten AK; Smith NMS; Martin IMC; Jones MR; Quinton LJ; Mizgerd JP
Mucosal Immunol; 2020 Mar; 13(2):334-343. PubMed ID: 31748706
[TBL] [Abstract][Full Text] [Related]
6. Limited Efficacy of Antibacterial Vaccination Against Secondary Serotype 3 Pneumococcal Pneumonia Following Influenza Infection.
Metzger DW; Furuya Y; Salmon SL; Roberts S; Sun K
J Infect Dis; 2015 Aug; 212(3):445-52. PubMed ID: 25649173
[TBL] [Abstract][Full Text] [Related]
7. Expression of activation-induced cytidine deaminase enhances the clearance of pneumococcal pneumonia: evidence of a subpopulation of protective anti-pneumococcal B1a cells.
Yamamoto N; Kerfoot SM; Hutchinson AT; Dela Cruz CS; Nakazawa N; Szczepanik M; Majewska-Szczepanik M; Nazimek K; Ohana N; Bryniarski K; Mori T; Muramatsu M; Kanemitsu K; Askenase PW
Immunology; 2016 Jan; 147(1):97-113. PubMed ID: 26456931
[TBL] [Abstract][Full Text] [Related]
8. The Influence of B Cell Depletion Therapy on Naturally Acquired Immunity to
Ercoli G; Ramos-Sevillano E; Nakajima R; de Assis RR; Jasinskas A; Goldblatt D; Felgner P; Weckbecker G; Brown J
Front Immunol; 2020; 11():611661. PubMed ID: 33584691
[TBL] [Abstract][Full Text] [Related]
9. A serotype 3 pneumococcal capsular polysaccharide-specific monoclonal antibody requires Fcγ receptor III and macrophages to mediate protection against pneumococcal pneumonia in mice.
Weber S; Tian H; van Rooijen N; Pirofski LA
Infect Immun; 2012 Apr; 80(4):1314-22. PubMed ID: 22290146
[TBL] [Abstract][Full Text] [Related]
10. CD8+ cells enhance resistance to pulmonary serotype 3 Streptococcus pneumoniae infection in mice.
Weber SE; Tian H; Pirofski LA
J Immunol; 2011 Jan; 186(1):432-42. PubMed ID: 21135172
[TBL] [Abstract][Full Text] [Related]
11. Lung-resident memory B cells established after pulmonary influenza infection display distinct transcriptional and phenotypic profiles.
Tan HX; Juno JA; Esterbauer R; Kelly HG; Wragg KM; Konstandopoulos P; Alcantara S; Alvarado C; Jones R; Starkey G; Wang BZ; Yoshino O; Tiang T; Grayson ML; Opdam H; D'Costa R; Vago A; ; Mackay LK; Gordon CL; Masopust D; Groom JR; Kent SJ; Wheatley AK
Sci Immunol; 2022 Jan; 7(67):eabf5314. PubMed ID: 35089815
[TBL] [Abstract][Full Text] [Related]
12. Controlled inflammatory responses in the lungs are associated with protection elicited by a pneumococcal surface protein A-based vaccine against a lethal respiratory challenge with Streptococcus pneumoniae in mice.
Lima FA; Ferreira DM; Moreno AT; Ferreira PC; Palma GM; Ferreira JM; Raw I; Miyaji EN; Ho PL; Oliveira ML
Clin Vaccine Immunol; 2012 Sep; 19(9):1382-92. PubMed ID: 22761301
[TBL] [Abstract][Full Text] [Related]
13. The endothelial protein C receptor impairs the antibacterial response in murine pneumococcal pneumonia and sepsis.
Schouten M; de Boer JD; Kager LM; Roelofs JJ; Meijers JC; Esmon CT; Levi M; van 't Veer C; van der Poll T
Thromb Haemost; 2014 May; 111(5):970-80. PubMed ID: 24401906
[TBL] [Abstract][Full Text] [Related]
14. Cellular senescence increases expression of bacterial ligands in the lungs and is positively correlated with increased susceptibility to pneumococcal pneumonia.
Shivshankar P; Boyd AR; Le Saux CJ; Yeh IT; Orihuela CJ
Aging Cell; 2011 Oct; 10(5):798-806. PubMed ID: 21615674
[TBL] [Abstract][Full Text] [Related]
15. Lethal coinfection of influenza virus and Streptococcus pneumoniae lowers antibody response to influenza virus in lung and reduces numbers of germinal center B cells, T follicular helper cells, and plasma cells in mediastinal lymph Node.
Wu Y; Tu W; Lam KT; Chow KH; Ho PL; Guan Y; Peiris JS; Lau YL
J Virol; 2015 Feb; 89(4):2013-23. PubMed ID: 25428873
[TBL] [Abstract][Full Text] [Related]
16. Mast cells impair host defense during murine Streptococcus pneumoniae pneumonia.
van den Boogaard FE; Brands X; Roelofs JJ; de Beer R; de Boer OJ; van 't Veer C; van der Poll T
J Infect Dis; 2014 Nov; 210(9):1376-84. PubMed ID: 24823624
[TBL] [Abstract][Full Text] [Related]
17. Trivalent pneumococcal protein recombinant vaccine protects against lethal Streptococcus pneumoniae pneumonia and correlates with phagocytosis by neutrophils during early pathogenesis.
Xu Q; Surendran N; Verhoeven D; Klapa J; Ochs M; Pichichero ME
Vaccine; 2015 Feb; 33(8):993-1000. PubMed ID: 25597944
[TBL] [Abstract][Full Text] [Related]
18. Lung bacterial clearance in murine pneumococcal pneumonia.
Ansfield MJ; Woods DE; Johanson WG
Infect Immun; 1977 Jul; 17(1):195-204. PubMed ID: 18404
[TBL] [Abstract][Full Text] [Related]
19. Involvement of the platelet-activating factor receptor in host defense against Streptococcus pneumoniae during postinfluenza pneumonia.
van der Sluijs KF; van Elden LJ; Nijhuis M; Schuurman R; Florquin S; Shimizu T; Ishii S; Jansen HM; Lutter R; van der Poll T
Am J Physiol Lung Cell Mol Physiol; 2006 Jan; 290(1):L194-9. PubMed ID: 16100290
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor 2 plays a role in the early inflammatory response to murine pneumococcal pneumonia but does not contribute to antibacterial defense.
Knapp S; Wieland CW; van 't Veer C; Takeuchi O; Akira S; Florquin S; van der Poll T
J Immunol; 2004 Mar; 172(5):3132-8. PubMed ID: 14978119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
